Literature DB >> 32748777

Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy.

Tiejun Shui1, Chao Shi2, Zhichun Jing2, Degang Yang2, Jianyu Zhu2.   

Abstract

Rifampicin is a highly effective antibacterial drug and an important component of multidrug therapy used to treat leprosy. Side effects of rifampicin are rare with the once-a-month dosage regimen of anti-leprosy multidrug therapy. Here, we report a case of rifampicin-induced thrombocytopenia during anti-leprosy treatment. Although rare, this potential side effect merits attention.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32748777      PMCID： PMC7543853          DOI： 10.4269/ajtmh.20-0211

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   3.707


  8 in total

1.  Do not miss rifampicin-induced thrombocytopenic purpura.

Authors:  Avinash Agrawal; Manish Gutch; Nirdesh Jain; Ambukeshwar Singh
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  Dapsone hypersensitivity syndrome: a clinico-epidemiological review.

Authors:  Sudha Agrawal; Arun Agarwalla
Journal:  J Dermatol       Date:  2005-11       Impact factor: 4.005

Review 3.  Insights of synthetic analogues of anti-leprosy agents.

Authors:  Smritilekha Bera; Dhananjoy Mondal
Journal:  Bioorg Med Chem       Date:  2019-05-02       Impact factor: 3.641

Review 4.  Treatment of leprosy.

Authors:  Hemanta Kumar Kar; Ruchi Gupta
Journal:  Clin Dermatol       Date:  2015 Jan-Feb       Impact factor: 3.541

5.  Glycoprotein Ib/IX complex is the target in rifampicin-induced immune thrombocytopenia.

Authors:  J Pereira; P Hidalgo; M Ocqueteau; M Blacutt; M Marchesse; Y Nien; L Letelier; D Mezzano
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

6.  Rifampin in the treatment of leprosy.

Authors:  W E Bullock
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

7.  History of chemotherapy of leprosy.

Authors:  Shaik K Noordeen
Journal:  Clin Dermatol       Date:  2015-10-28       Impact factor: 3.541

Review 8.  A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing.

Authors:  Na Wang; Leela Parimi; Hong Liu; Furen Zhang
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.